- Home
- PRTA vs SITC Comparison
PRTA vs SITC Comparison
Compare PRTA & SITC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- SITC
- Stock Information
- Founded
- PRTA 2012
- SITC 1965
- Country
- PRTA Ireland
- SITC United States
- Employees
- PRTA N/A
- SITC N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- SITC Real Estate Investment Trusts
- Sector
- PRTA Health Care
- SITC Real Estate
- Exchange
- PRTA Nasdaq
- SITC Nasdaq
- Market Cap
- PRTA 802.8M
- SITC 896.4M
- IPO Year
- PRTA N/A
- SITC 1993
- Fundamental
- Price
- PRTA $14.01
- SITC $15.61
- Analyst Decision
- PRTA Buy
- SITC Hold
- Analyst Count
- PRTA 7
- SITC 10
- Target Price
- PRTA $57.67
- SITC $42.53
- AVG Volume (30 Days)
- PRTA 476.3K
- SITC 1.3M
- Earning Date
- PRTA 11-12-2024
- SITC 10-30-2024
- Dividend Yield
- PRTA N/A
- SITC 5.83%
- EPS Growth
- PRTA N/A
- SITC 757.51
- EPS
- PRTA N/A
- SITC 13.71
- Revenue
- PRTA $133,350,000.00
- SITC $451,683,000.00
- Revenue This Year
- PRTA $60.63
- SITC N/A
- Revenue Next Year
- PRTA N/A
- SITC N/A
- P/E Ratio
- PRTA N/A
- SITC $1.14
- Revenue Growth
- PRTA N/A
- SITC N/A
- 52 Week Low
- PRTA $14.00
- SITC $15.52
- 52 Week High
- PRTA $41.55
- SITC $64.44
- Technical
- Relative Strength Index (RSI)
- PRTA 31.91
- SITC 20.68
- Support Level
- PRTA $17.27
- SITC $15.81
- Resistance Level
- PRTA $18.60
- SITC $16.51
- Average True Range (ATR)
- PRTA 1.11
- SITC 0.42
- MACD
- PRTA -0.15
- SITC 0.75
- Stochastic Oscillator
- PRTA 0.20
- SITC 5.25
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About SITC SITE Centers Corp.
SITE Centers Corp is a United States-based self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing and managing shopping centers.